Signalpoint

← Full daily brief

Mass Tort brief

Teva Navigates Paragard Bellwether and Opioid Bond Backlash

Key legal rulings and pension fund activist pressures surrounding Israeli pharmaceutical giant Teva in US multidistrict litigation.

Signalpoint TeamBrief

Mass Tort

Teva's New Jersey summary judgment victory gives the drugmaker key leverage entering a 4,200-case bellwether trial — reshaping litigation risk expectations on TASE.

BackgroundMultidistrict litigation consolidates thousands of similar product liability lawsuits before a single federal judge to streamline pretrial discovery. Bellwether trials test jury reactions to determine potential global settlement valuations for mass tort claims.

Points
  1. Plaintiffs allege the Paragard copper contraceptive device breaks upon removal, causing severe internal injuries and requiring emergency surgical intervention.
  2. The next bellwether trial, Robere v. Teva, begins September 28 in Georgia federal court, serving as a primary test case for settlement pricing.
  3. Teva Pharmaceutical Industries faces litigation reserve scrutiny on TASE as market analysts track bellwether outcomes to gauge potential liability exposure.
SourcesButler Snow: Butler Snow Secures Summary Judgment for Teva in New Jersey Product Liability Litigation (opens in new tab)

Mass Tort

Pension divestment pressure over Teva's $4.25B opioid settlement shows legacy mass tort liabilities still dog the Israeli drugmaker in US local politics.

BackgroundTel Aviv-headquartered Teva finalized a $4.25 billion global settlement in 2023 to resolve thousands of state and local government lawsuits over historic opioid marketing. Pension fund divestment campaigns periodically target foreign and domestic companies resolving legacy mass tort liabilities.

Points
  1. The Jacksonville Police and Fire Pension Fund manages municipal retirement assets with $2M in Teva corporate bond maturities arriving October 1.
  2. Protesters cited Teva's mass tort liabilities alongside political objections to foreign corporate bond holdings in municipal retirement portfolios.
  3. Teva has fully funded its multi-year opioid settlement payouts from operating cash flows, maintaining steady debt servicing and liquidity reserves.
SourcesWOKV / Jacksonville Today: IN DEPTH: Jacksonville group wants Police and Fire Pension Fund to stop investing in Teva (opens in new tab)

Unlock the full brief

Sign in to read every signal, takeaway, and source. Free account — Apple, Google, or email.

Or read free in the appDownload on the App Store